Public health, innovation, intellectual property and trade

Financing

Current activities related to financing fall under the purview of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). WHO Member States have requested the establishment of this working group in response to a concern that insufficient resources were being devoted globally to research and development (R&D) to address treatments for diseases that principally affect developing countries.

The CEWG is mandated to examine R&D financing and coordination proposals for diseases that principally affect developing countries.

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



Contacts

Public health, innovation, intellectual property and trade
phidepartment@who.int

Dr Suzanne Hill
Director, EMP
Essential Medicines and Health Products (EMP)

Dr Marie-Paule Kieny
Assistant Director-General, HIS
Health Systems and Innovation (HIS)